IRhythm Technologies Debt to Equity Ratio 2015-2023 | IRTC
Current and historical debt to equity ratio values for IRhythm Technologies (IRTC) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. IRhythm Technologies debt/equity for the three months ending December 31, 2023 was 0.17.
| IRhythm Technologies Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2023-12-31 | $0.22B | $0.21B | 1.06 |
| 2023-09-30 | $0.22B | $0.22B | 1.00 |
| 2023-06-30 | $0.21B | $0.22B | 0.92 |
| 2023-03-31 | $0.20B | $0.22B | 0.90 |
| 2022-12-31 | $0.21B | $0.24B | 0.87 |
| 2022-09-30 | $0.20B | $0.24B | 0.84 |
| 2022-06-30 | $0.19B | $0.25B | 0.78 |
| 2022-03-31 | $0.18B | $0.25B | 0.75 |
| 2021-12-31 | $0.18B | $0.28B | 0.66 |
| 2021-09-30 | $0.18B | $0.30B | 0.62 |
| 2021-06-30 | $0.18B | $0.31B | 0.58 |
| 2021-03-31 | $0.17B | $0.31B | 0.55 |
| 2020-12-31 | $0.17B | $0.34B | 0.50 |
| 2020-09-30 | $0.16B | $0.34B | 0.49 |
| 2020-06-30 | $0.16B | $0.12B | 1.34 |
| 2020-03-31 | $0.16B | $0.13B | 1.26 |
| 2019-12-31 | $0.17B | $0.14B | 1.26 |
| 2019-09-30 | $0.17B | $0.14B | 1.18 |
| 2019-06-30 | $0.16B | $0.05B | 3.27 |
| 2019-03-31 | $0.07B | $0.05B | 1.36 |
| 2018-12-31 | $0.07B | $0.05B | 1.25 |
| 2018-09-30 | $0.06B | $0.06B | 0.86 |
| 2018-06-30 | $0.05B | $0.07B | 0.77 |
| 2018-03-31 | $0.05B | $0.07B | 0.68 |
| 2017-12-31 | $0.05B | $0.08B | 0.67 |
| 2017-09-30 | $0.05B | $0.09B | 0.57 |
| 2017-06-30 | $0.05B | $0.09B | 0.54 |
| 2017-03-31 | $0.04B | $0.09B | 0.49 |
| 2016-12-31 | $0.05B | $0.09B | 0.49 |
| 2016-09-30 | $0.05B | $-0.02B | -2.54 |
| 2016-06-30 | $0.04B | $-0.01B | -3.03 |
| 2016-03-31 | $0.00B | $0.00B | 0.00 |
| 2015-12-31 | $0.00B | 0.00 | |
| 2015-09-30 | $0.00B | $0.00B | 0.00 |
| 2015-06-30 | $0.00B | $0.00B | 0.00 |
| 2014-12-31 | $0.01B | $0.00B | 3.14 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $3.483B | $0.493B |
| iRhythm Technologies, Inc. is a digital healthcare company. It focuses on the provision of ambulatory electrocardiogram, monitoring for patients at risk for arrhythmias primarily in the United States. The company offers ZIO Service, a platform which provides wearable biosensor with cloud-based data analytics that distill data from heartbeats into clinically actionable information. iRhythm Technologies, Inc. is headquartered in San Francisco, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $39.354B | 21.89 |
| Inspire Medical Systems (INSP) | United States | $7.194B | 0.00 |
| Axonics (AXNX) | United States | $3.401B | 0.00 |
| 10x Genomics (TXG) | United States | $3.288B | 0.00 |
| Enovis (ENOV) | United States | $3.030B | 23.02 |
| Azenta (AZTA) | United States | $2.910B | 237.18 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.840B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.678B | 0.00 |
| Privia Health (PRVA) | United States | $2.167B | 96.11 |
| Schrodinger (SDGR) | United States | $1.733B | 0.00 |
| Omnicell (OMCL) | United States | $1.279B | 31.30 |
| Phreesia (PHR) | United States | $1.162B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.823B | 0.00 |
| Standard BioTools (LAB) | United States | $0.708B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.601B | 0.00 |
| Talkspace (TALK) | United States | $0.527B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.353B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.337B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.328B | 0.00 |
| Pulmonx (LUNG) | United States | $0.281B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.162B | 0.00 |
| American Well (AMWL) | United States | $0.153B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.141B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.141B | 0.00 |
| Augmedix (AUGX) | United States | $0.139B | 0.00 |
| Outset Medical (OM) | United States | $0.124B | 0.00 |
| TruBridge (TBRG) | United States | $0.118B | 5.03 |
| 111 (YI) | China | $0.086B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.082B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.073B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.048B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.035B | 0.00 |
| Movano (MOVE) | United States | $0.026B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Cue Health (HLTH) | United States | $0.022B | 0.00 |
| Akili (AKLI) | United States | $0.019B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.018B | 0.00 |
| CareCloud (CCLD) | United States | $0.017B | 0.00 |
| ETAO (ETAO) | United States | $0.015B | 0.00 |
| Biotricity (BTCY) | United States | $0.012B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |